The recent NHANES III United States survey of ~17,000 subjects without apparent thyroid disease, reported detectable TPOAb levels in 12 % of subjects using a competitive immunoassay method.

Ever since the development of the first radioimmunoassay in 1959, numerous competitive assays have been developed with the goal of sensitive detection of such analytes, and such an assay could ...